These authors also found that the knockdown of CaMKK2 or its pharmacological inhibition using a selective inhibitor STO-609 or inhibition of the CaMKK2-target protein AMPK abrogates PCa cell migration and invasion (68, 87, 105). This evidence concerns the gene CAMKK2 and posterior cortical atrophy.